FDA Drug Application (021636) for ZEGERID by SANTARUS INC

Back to FDA Applications sponsored by SANTARUS INC

Application Number021636
Product Number001
FormFOR SUSPENSION;ORAL
Dosage20MG/PACKET;1.68GM/PACKET
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameZEGERID
Active IngredientOMEPRAZOLE; SODIUM BICARBONATE

Active IngredientCount
List of drugs with Active Ingredient MAGNESIUM HYDROXIDE4
List of drugs with Active Ingredient OMEPRAZOLE8
List of drugs with Active Ingredient SODIUM BICARBONATE53


Back to FDA Applications sponsored by SANTARUS INC